FGF and TGF-β growth factor isoform modulation of human gingival and periodontal ligament fibroblast wound healing phenotype

Matrix Biol. 2025 Apr:136:9-21. doi: 10.1016/j.matbio.2024.12.011. Epub 2025 Jan 3.

Abstract

Release of growth factors in the tissue microenvironment is a critical process in the repair and regeneration of periodontal tissues, regulating fibroblast behavior and phenotype. As a result of the complex architecture of the periodontium, distinct fibroblast populations in the periodontal ligament and gingival connective tissue exist in close proximity. Growth factor therapies for periodontal regeneration have gained traction, but quantification of their effects on multiple different fibroblast populations that are required for repair has been poorly investigated. In this study, we examined the effects of TGF-β1, TGF-β3, FGF-2, and FGF-9 on human gingival fibroblasts (hGF) and human periodontal ligament cells (hPDL), as well as the combined effects of TGF-β3 and FGF-2. We show that FGF-2 enhances cell migration while TGF-β1 and TGF-β3 promotes matrix production, and TGF-β1 promotes fibroblast to myofibroblast transition. Interestingly, the combination of TGF-β3 and FGF-2, acting through both p-SMAD3 and p-ERK pathways, mitigates the inhibitory effects of TGF-β3 on migration in hPDL cells, suggesting synergistic and complimentary effects of FGF-2 and TGF-β3. Additionally, fibronectin production in hGF increased when treated with the combined TGF-β3+FGF-2 compared to FGF-2 alone, indicating that the effects of TGF-β3 in promoting extracellular matrix production are still active in the combined treatment condition. Finally, our study highlights that FGF-9 did not influence migration, α-SMA expression, or extracellular matrix production in either cell type, emphasizing the unique roles of specific growth factors in cellular responses. The synergistic effects observed with combined TGF-β3 and FGF-2 treatments present promising avenues for further research and clinical advancements in regenerative medicine.

Keywords: Extracellular matrix; FGF-2; Growth factor combination; Myofibroblast; TGF-β1.

Publication types

  • Comparative Study
  • Video-Audio Media

MeSH terms

  • Cell Differentiation / drug effects
  • Cell Movement / drug effects
  • Cellular Microenvironment
  • Extracellular Matrix Proteins / metabolism
  • Fibroblast Growth Factor 2* / pharmacology
  • Fibroblast Growth Factor 9* / pharmacology
  • Fibroblast Growth Factors / pharmacology
  • Fibroblast Growth Factors / therapeutic use
  • Fibroblasts* / cytology
  • Fibroblasts* / drug effects
  • Fibroblasts* / metabolism
  • Gingiva* / cytology
  • Gingiva* / drug effects
  • Periodontal Ligament* / cytology
  • Periodontal Ligament* / drug effects
  • Phenotype
  • Primary Cell Culture
  • Transforming Growth Factor beta* / pharmacology
  • Wound Healing / drug effects

Substances

  • Fibroblast Growth Factors
  • Transforming Growth Factor beta
  • TGFB1 protein, human
  • TGFB3 protein, human
  • Fibroblast Growth Factor 2
  • Fibroblast Growth Factor 9
  • Extracellular Matrix Proteins
  • ACTA2 protein, human